About thirty healthcare and research professionals from institutions belonging to the Can Ruti Campus, among the world’s most renowned scientists

Antoni Bayés, Pere Joan Cardona, Magí Farré, Miquel Àngel Gassull, Manel Puig-Domingo, Manuel Perucho and Jordi Barretina, all past and present members of IGTP staff together with nearly twenty other affiliated researchers and medical staff from Can Ruti Campus institutions -many affiliated to the IGTP- are included in Elsevier's Scopus list, composed of the 200,000 most renowned researchers worldwide.

A scientific project led by Beatriz Mothe receives the Young Researchers Award from the AstraZeneca Foundation

• The project aims to contribute to the design of more universal therapies for COVID-19 with efficacy in more vulnerable groups, such as people with immunosuppression
• The awards are an initiative to promote the development and consolidation of young scientific talent in Spain

Open doors morning for the second year of baccalaureate students of the Col·legi Cultural de Badalona

Yesterday morning, a group of second year of scientific baccalaureate students of the Col·legi Cultural de Badalona visited the IGTP. They had the opportunity to see the facilities and learn about basic research pratices.

The IGTP hosts the EORTC Pathobiology Group (PBG) Annual Meeting

The European Organisation for Research and Treatment of Cancer (EORTC) Pathobiology Group Annual Meeting took place on October 24 and 25, organized jointly by the Catalan Institute of Oncology (ICO) and the Germans Trias i Pujol Research Institute (IGTP). Over the two-day event, a series of talks on therapies to fight cancer were held both at the IGTP facilities and online.

The IGTP organizes the EATRIS Spain workshop, a meeting point for advances in translational research

The workshop "Advances in Translational Research through EATRIS", organized by the IGTP took place this week and provided a space for researchers to discuss the role of EATRIS as a European infrastructure of translational research. 

The IGTP presents CARE Translational Program in Cancer Research

CARE, the Translational Program in Cancer Research is the first transversal program promoted by the Germans Trias i Pujol Research Institute (IGTP), and it aims to become a bridge for researchers in the field of cancer who want to bring basic and clinical research together, so that the knowledge and the tools generated in the laboratory can benefit the patient.

The CEEISCAT participates in the Annual Meeting of the Spanish Society of Epidemiology around the "Challenges of the 21st century"

One more year, the Spanish Society of Epidemiology (SEE) has organized its annual congress, this year in Donostia (Euskadi), where more than 800 people have participated at the University of the Basque Country/Euskal Herriko Unibersitatea (UPV/EHU). The Center for Epidemiological Studies on Sexually Transmitted Infections and AIDS of Catalonia (CEEISCAT), as a research group of the Germans Trias i Pujol Research Institute (IGTP), presented a total of 19 oral communications in their respective fields of work and moderated two oral communication sessions and presented a poster. In addition, Dr. Jordi Casabona, as the director of the center, was invited to make a presentation on the Monkeypox virus.

The director of IrsiCaixa Bonaventura Clotet is awarded the 2020 'Premi Nacional de Recerca'

Dr Bonaventura Clotet, Director of IrsiCaixa and member of the Board of Trustees of the IGTP has been awarded the prestigious 'Premi Nacional de Recerca' in recognition of his contribution to science with his work on infectious diseases, especially HIV and AIDS.

Only half of the scientific conferences and events organized on our campus reach the objectives of the European Commission for gender equality

This is the second year that the WiS Group have monitored the scientific activity on Can Ruti Campus.

The start of a new international clinical trial to improve treatment for tuberculosis with anti-inflammatory agents

The Experimental Tuberculosis Group at the IGTP has set up this trial, coordinated from Can Ruti, within the European project H2020 ‘SMA-TB’. The study will evaluate the efficacy and safety of adding acetylsalicylic acid or ibuprofen to the antibiotic treatments applied for tuberculosis. It is a phase II trial which will be carried out in South Africa and Georgia, two of the countries the WHO has in its sights to control this infectious disease. The trial has been prepared in the midst of the pandemic, with the added challenge of coordinating it with the restrictions and different stages of the epidemic in each of the countries involved.